Skip to content

18F-FAPI PET-CT imaging for myocardial fibrosis detection

18F-FAPI PET-CT imaging for myocardial fibrosis detection

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069373
Enrollment
Unknown
Registered
2023-03-14
Start date
2022-03-28
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients (age 18-80 years or above), gender is not limited; 2. Patients with clinically suspected or confirmed heart failure (supporting evidence includes History taking, cardiac MRI, cardiac ultrasound, and serological indicators, etc.), and patients who agree to undergo 18F-FAPI imaging; 3. The patient or his legal representative can sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute systemic diseases and electrolyte disorders; 2. Pregnant or lactating women; 3. Patients refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
cardiac fibroblast activation standard uptake values;

Secondary

MeasureTime frame
Left ventricular ejection fraction;

Countries

China

Contacts

Public ContactFangfang Sun

The First Affiliated Hospital of Dalian Medical University

sf.f@163.com+86 180 9887 6916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026